Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries-Reference-Cited by-同舟云学术

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries

Published:2017-10-17 Issue:2 Volume:32 Page:245-253
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Busard C.I.¹,Cohen A.D.²,Wolf P.³,Gkalpakiotis S.⁴,Cazzaniga S.⁵⁶,Stern R.S.⁷,Hutten B.A.⁸,Feldhamer I.²,Quehenberger F.⁹,Lichem R.³,Kojanova M.¹⁰,Adenubiova E.⁴,Addis A.¹¹,Naldi L.⁵,Spuls P.I.¹

Affiliation:

1. Department of Dermatology; Academic Medical Center; University of Amsterdam; Amsterdam The Netherlands

2. Department of Quality Measurements and Research; Clalit Health Services; Tel-Aviv Israel

3. Department of Dermatology; Medical University of Graz; Graz Austria

4. Department of Dermatovenereology; Third Faculty of Medicine; Charles University and University Hospital of Kralovske Vinohrady; Prague Czech Republic

5. Centro Studi GISED; Fondazione per la Ricerca; Ospedale Maggiore; Bergamo Italy

6. Dermatology Department; Inselspital University Hospital; Bern Switzerland

7. Beth Israel Deaconess Medical Center; Harvard Medical School; Boston MA USA

8. Department of Clinical Epidemiology; Biostatistics and Bioinformatics; Academic Medical Center; University of Amsterdam; Amsterdam The Netherlands

9. Institute for Medical Informatics; Statistics and Documentation; Medical University of Graz; Graz Austria

10. Department of Dermatovenereology; Charles University; First Faculty of Medicine and General University Hospital; Prague Czech Republic

11. Department of Epidemiology; Servizio Sanitario Regionale; Regione Lazio Italy

Funder

EADV and Italian Drug Agency AIFA

Department of Dermatology of the Academic Medical Centre

Czech Society of Dermatology and Venereology

Österreichische Gesellschaft für Dermatologie und Venerologie

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14583/fullpdf

Reference40 articles.

1. Experience with biologics for psoriasis in daily practice: switching is worth a try;Lecluse;Br J Dermatol,2009

2. Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs;Moots;Clin Exp Rheumatol,2015

3. Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy;Brezinski;PLoS ONE,2012

4. Use of biologic agents in combination with other therapies for the treatment of psoriasis;Cather;Am J Clin Dermatol,2014

5. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up;Bartelds;JAMA,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-12

2. Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-10-31

3. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry;British Journal of Dermatology;2023-10-17

4. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists;Dermatologic Therapy;2022-09-22

5. Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial;Journal of Investigative Dermatology;2022-09